Skip to main content
. 2019 Nov;15(4):197–206. doi: 10.2174/1573396315666190617151745

Table 4. Clinical features and pathogens defining the presence of a protozoan OI.

Protozoa Clinical Condition
Babesia spp [45, 46] Severe disease with anemia, pulmonary and renal involvment; persisting and relapsing disease.
Toxoplasma gondii [15, 16, 19] Toxoplasmosis of the central nervous system with onset at age ≥ 1 month.
Visceral disseminated toxoplasmosis, (e.g. lungs).
Cryptosporidium [15, 16, 19] Cryptosporidiosis, chronic diarrhea (>1 month duration).
Giardia [14, 15] Giardiasis, chronic intestinal diarrhea >1 month duration).
Isospora [14, 15] Chronic diarrhea (>1 month duration).
Microsporidium [14, 15] Chronic diarrhea (>1 month duration) Anncaliia algerae myositis.
Leishmania [47, 48] Recurrent, atypical visceral leishmania.
Trypanosoma cruzi [16, 49] Reactivation of American trypanosomiasis: Meningoencephalitis, central nervous system mass, myocarditis.
Acanthamoeba spp. [50] Meningoencephalitis, granulomatous amoebic encephalitis.
Balamuthia mandrillaris [51] Meningoencephalitis, granulomatous amoebic encephalitis.
Naegleria fowleri [51] Meningoencephalitis, granulomatous amoebic encephalitis.